Abstract:Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be promptly diagnosed and treated. The diagnosis, risk assessment, and management of pulmonary embolism have evolved with a better understanding of efficient use of diagnostic and therapeutic options. The use of either clinical probability adjusted or age adjusted D-dimer interpretation has led to a reduction in diagnostic imaging to exclude pulmonary embolism. Direct oral anticoagulation therapies are safe, effective, and convenient treatments for most patients with acute venous thromboembolism, with a lower risk of bleeding than vitamin K antagonists. These oral therapeutic options have opened up opportunities for safe outpatient management of pulmonary embolism in selected patients. Recent clinical trials exploring the use of systemic thrombolysis in intermediate to high risk pulmonary embolism suggest that this therapy should be reserved for patients with evidence of hemodynamic compromise. The role of low dose systemic or catheter directed thrombolysis in other patient subgroups is uncertain. After a diagnosis of pulmonary embolism, all patients should be assessed for risk of recurrent venous thromboembolism to guide duration of anticoagulation. Patients with a venous thromboembolism associated with a strong, transient, provoking risk factor can safely discontinue anticoagulation after three months of treatment. Patients with an ongoing strong risk factor, such as cancer, or unprovoked events are at increased risk of recurrent events and should be considered for extended treatment. The use of a risk prediction score can help to identify patients with unprovoked venous thromboembolism who can benefit from extended duration therapy. Despite major advances in the management of pulmonary embolism, up to half of patients report chronic functional limitations. Such patients should be screened for chronic thromboembolic pulmonary hypertension, but only a small proportion will have this as the explanation of their symptoms. In the remaining patients, future studies are needed to understand the pathophysiology and explore interventions to improve quality of life.

Controversy and consensus on the diagnosis and treat-ment of Perioperative venous thromboembolism diseases

Perioperative Intervention to Prevent Lower Extremity Deep Venous Thrombosis after Gynecologic Surgery

Several critical issues of prevention and management for the perioperative venous thrombosis

Prevention of deep vein thrombosis and pulmonary embolus

Emphasis on coagulation problems and laboratory indicators in post-operative patients

Pulmonary embolism: update on management and controversies

Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery

[Current Status and Prospect of Perioperative Thrombus Management in Gastrointestinal Cancer].

Advances in the Diagnosis of Venous Thromboembolism: A Literature Review

Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline

Research Progress on Prevention of Deep Venous Thrombosis among Abdominal and Pelvic Cancer Patients During Perioperative Period

Expert consensus on diagnosis, prevention and treatment of perioperative lower extremity vein thrombosis in orthopedic trauma patients (2022 edition)

Experts' Consensus on Perioperative Management of Tooth Extractions in Patients Receiving Oral Antithrombotic Treatment

[Perioperative Management of Deep Vein Thrombosis and Treatment of Pulmonary Embolism]

Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline

Prevention and management of venous thromboembolic disease following lower extremity total joint arthroplasty

Venous Interventions: Controversies in the Management of Acute Deep Venous Thrombosis and the Role of the Interventional Radiologist

Update and explanation of venous thrombosis guideline of European Society of Vascular Surgery

The diagnosis and management of postoperative pulmonary embolism

Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism—can death from pulmonary embolism be prevented?

Current situation and trend of treatment of deep vein thrombosis